32

PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues
Page 2: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

2

Page 3: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

3

Page 4: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Myers, A. G.; Seiple, I. B.; Zhang. Z.; Jakubec, P.; Mercier, A. L. et al. Nature, 2016, 53, 338-355.

4

Page 5: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

The term ‘desmethyl’ refes to the replacement

of a methyl group with hydrogen (Me -> H).

5

Andrade, R. B. Synlett., 2015, 26, 2199–2215

Page 6: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Andrade’s purpose of this synthesis

-why 4-desmethyl telithromycin?-

6

Figure 1

(A) telithromycin and A2058 interactions

(B) consequences of A2058G mutation

• ribosomal mutation of adenine to guanine at position 2058 resulted in a steric clash between the C-4

methyl group of the macrolide/ketolide and the exocyclic amino group of guanine (Figure 1).

• the author hypothesized that ‘mutating’ the C-4 methyl group into hydrogen (producing desmethyl

analogues) would recapitulate binding and restore bioactivity against such resistant strains.

Tu, D.; Blaha, G.; Moore, P. B.; Steitz, T. A. Cell 2005, 121, 257.

Page 7: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

7

Page 8: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

8

Page 9: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

9

Page 10: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

10

Page 11: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

11

Page 12: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Total Synthesis of

4-desmethyl telithromycin (4)

12

Page 13: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

13

Page 14: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

14

Page 15: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

15

Page 16: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Biological evaluation of desmethyl

telithromycin analogues

16

Table 1 Biological evaluation of analogues of telithromycin showing Minimum Inhibitory Concentration Values for 4,8,10-

telithromycin (3), 4,10-telithromycin (4), 4,8-telithromycin (5), 4-telithromycin (6), and comparator telithromycin (2)

The total syntheses of 3-6 allowed to test the……

(1) the roles of the C-4, C-8 and C-10 methyl groups on biological activity.

(2) the desmethylation hypothesis (replacing the 4-methyl group with

hydrogen would avoid the attendant steric clash with ribosomes

bearing the A2058G mutation).

(1) as methyl groups are progressively added to the macrolide, the

antibacterial activity increase.

(2) 6 was fourfold less potent than 2 against the A2058G mutant.

Page 17: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

17

Page 18: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Synthetic strategy

18

Page 19: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

19

Page 20: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

4.3 g 20

Page 21: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

21

Page 22: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

22

Page 23: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

23

Page 24: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

17 g scale

10 g scale

24

Page 25: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

10 g scale

25

Page 26: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

17 g scale

10 g scale

26

Page 27: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Evaluation for

antibiotic

activity

>300 fully synthetic macrolide

antibiotic candidates were

prepared to modify readily

diversifiable elements.

a majority of compounds in

the candidates exhibit

demonstrable antibiotic

activity.

27

Page 28: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

28

Page 29: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

29

Appendix

Page 30: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

1,2-trans type glycosylation

30

Neighboring group participation

Appendix

Page 31: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Baker cyclization

31

Baker, W.R.; Clark, J. D.; Stephens, R. L.; Kim. K. H. J. Org. Chem., 1988,53, 2340-2345.

Appendix

Page 32: PowerPoint プレゼンテーションinoue/assets/img/archive-pdf/160709...Biological evaluation of desmethyl telithromycin analogues 16 Table 1 Biological evaluation of analogues

Stereochemical of carbamate

32

Figure A-1 Four low energy conformations of the unsaturated ketone (derived from erythromycin)

with calculated (MM2) energies of (A) 58.8, (B) 52.3, (C) 56.6, and (D) 53.7 kcal/mol.

Baker, W.R.; Clark, J. D.; Stephens, R. L.; Kim. K. H. J. Org. Chem., 1988,53, 2340-2345.

Appendix